These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2497985)

  • 1. Improved skin adherence and patient acceptance in a new transdermal nitroglycerin delivery system.
    Hougham AJ; Hawkinson RW; Crowley JK; Wilson RR; Glode JE; Hilty RW; Hughes SO; Koeppl CG; Kovaric TR; Wyskoarko NP
    Clin Ther; 1989; 11(1):23-31. PubMed ID: 2497985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved comfort and patient acceptance in a novel transdermal nitroglycerin delivery system.
    Hougham AJ; Hawkinson RW; Crowley JK; Wilson RR; Brown SG; Dougherty PJ; Fogel MA; Hash VW; Rietbrock MJ
    Clin Ther; 1989; 11(1):15-22. PubMed ID: 2497982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of two transdermal nitroglycerin systems: Transderm-Nitro and Nitro-Dur.
    Riley S; Morris B; Walker L; Reese P; White L
    Clin Ther; 1992; 14(3):438-45. PubMed ID: 1638585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of two transdermal nitroglycerin systems.
    Godoy C; Greenspahn BR; Kushner MJ; Lahti RE; Levy RA; Reese P; Reynolds GM; Rice SC
    Clin Ther; 1986; 8(6):689-93. PubMed ID: 3098427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative evaluation of two transdermal nitroglycerin delivery systems: Nitro-Dur versus Transderm-Nitro. The Collaborative Investigation Group.
    Clin Ther; 1991; 13(5):545-9. PubMed ID: 1799911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of adhesive properties of two transdermal nitroglycerin controlled-release systems.
    Chinoy DA; Breaux PC; Ibrahim F
    Clin Ther; 1985; 8(1):30-4. PubMed ID: 3938681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter comparison of adhesion, preference, tolerability, and safety characteristics of two transdermal nitroglycerin delivery systems: Transderm-Nitro and Deponit.
    Chinoy DA; Camp J; Elchahal S; Godoy C; Grossman W; Hai H; Hamilton W; Kushner M; McGreevy M; Mulvihill RJ
    Clin Ther; 1989; 11(5):678-84. PubMed ID: 2509071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adhesion-to-skin performance of a new transdermal nitroglycerin adhesive patch.
    Wick KA; Wick SM; Hawkinson RW; Holtzman JL
    Clin Ther; 1989; 11(3):417-24. PubMed ID: 2501033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of angina pectoris with nitroglycerin plasters. A multicenter study involving 6,986 patients.
    Agabiti Rosei E; Muiesan ML; Pollavini G; Bichisao E; Muiesan G
    Int J Clin Pharmacol Ther Toxicol; 1987 Oct; 25(10):572-81. PubMed ID: 3123406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal nitroglycerin systems: methods for comparison.
    Harrison LI; Riedel DJ
    Clin Ther; 1991; 13(3):361-7. PubMed ID: 1954637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tolerance and effectiveness of transdermal nitroglycerin in angina pectoris. A multicenter study. Adesitrin Italian Study Group].
    Strano A; Luca C; Pamparana F
    Cardiologia; 1990 Jan; 35(1):41-8. PubMed ID: 2115818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained effects of transdermal nitroglycerin in patients with angina pectoris.
    Kapoor AS; Dang NS; Reynolds RD
    Clin Ther; 1985; 7(6):674-9. PubMed ID: 3935313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transdermal nitroglycerin in patients with stable angina].
    Ramires JA; Ghorayeb N; Mansur AP; Batlouni M; Oliveira SF; da Luz PL
    Arq Bras Cardiol; 1992 Feb; 58(2):141-7. PubMed ID: 1307460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative acceptance of three transdermal nitroglycerin placebo patches.
    Rayment CM; Kaul AF; Garfield JM
    Am J Hosp Pharm; 1985 Jun; 42(6):1362-5. PubMed ID: 3925770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The development of tolerance to continuous transdermal nitroglycerin therapy in patients with angina of effort and mixed angina].
    Cianfrocca C; Sabia R; Zoboli S; Bugiardini R
    G Ital Cardiol; 1993 May; 23(5):439-49. PubMed ID: 8339869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of three transdermal nitroglycerin controlled-release systems.
    Hay JW
    Clin Ther; 1988; 10(4):450-5. PubMed ID: 3152619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal nitroglycerin (Transiderm-Nitro) in the treatment of unstable angina pectoris.
    Dahlstrøm CG; Rasmussen K; Bagger JP; Henningsen P; Haghfelt T
    Dan Med Bull; 1986 Oct; 33(5):265-7. PubMed ID: 3096643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic effects of transdermal nitroglycerin in stable angina pectoris: a within-patient, placebo-controlled study.
    Gibelli G; Negrini M; Bruno AM; Fiorini GL; Lambiase M; Magenta G; Corti D; Prina L; Pollavini PG; De Ponti C
    Int J Clin Pharmacol Ther Toxicol; 1989 Sep; 27(9):436-41. PubMed ID: 2509380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of transdermal nitroglycerin therapy with previous long-acting oral or ointment nitrate therapy.
    Chinoy DA
    Clin Ther; 1987; 9(5):466-73. PubMed ID: 3117368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terlipressin plus transdermal nitroglycerin vs. octreotide in the control of acute bleeding from esophageal varices: a multicenter randomized trial.
    Silvain C; Carpentier S; Sautereau D; Czernichow B; Métreau JM; Fort E; Ingrand P; Boyer J; Pillegand B; Doffël M
    Hepatology; 1993 Jul; 18(1):61-5. PubMed ID: 8325622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.